Abstract:The single enantiomers of seven hydroxyl-substituted biphenyl-diarylpyrimidines were designed and synthesized by a bioisosterism strategy as novel HIV-1 non-nucleoside reverse transcriptase inhibitors (NNRTIs). The cellular and enzymatic assays indicated that the novel obtained compounds had significant activities and relatively low cytotoxicity. The supercritical fluid chromatography (SFC) enantioseparations of the racemic compounds and the enantiomeric profiling resulted that the (S) forms were generally more potent than the (R) counterparts. Among all the chiral derivatives, (S)-(-)-12a showed the best potency with the antiviral activities against wild-type (WT) and single mutant strains (L100I, K103 N, Y181C, E138K; especially Y188L), and RT enzyme in the low nanomolar concentration range. Toward double mutant virus strains (F227L + V106A, RES056), (S)-(-)-12a possessed submicromolar antiviral activities. In addition, (S)-(-)-12a showed a high cell-based selectivity index (SI WT = 5822) and no apparent toxicity was observed in the in vivo acute toxicity assay and electrocardiogram. The molecular docking studies predicted the binding modes of the compounds with RT and explained the activity differences for the enantiomers. Although the rat pharmacokinetic assay indicated a poor oral metabolism of the hydroxyl compound, the promising antiviral activity of the chiral hydroxyl-substituted biphenyl-diarylpyrimidines provided valuable lead compounds for further anti-HIV drug design. (C) 2020 Elsevier Masson SAS. All rights reserved.

Synthetic studies of the HIV-inhibitive marine natural products synthesis of the C1 similar to C7 fragment of didemnaketal A

Efficient Synthesis of the C1-C7 Fragment of Didemnaketal A

Synthetic studies of the HIV-inhibitive spiroketals - Construction of the C(1)similar to C(8) intermediate of didemnaketals

Synthetic Studies of HIV-active Didemnaketal A Analogue - Synthesis of a C1 - C7 Fragment

Synthetic studies of HIV-active Didemnaketal A analogue - Synthesis of a C1-C7 fragment

Synthetic Studies of Hiv-Active Didemnaketal A Analogue - Synthesis of A C8-C15 Fragment

Synthesis of Chiral Intermediate (3S,5s,6s)-3,7-dimethyl-5,6-dihydroxy-7-en-octanal of Didemnaketals Analogue

Synthetic studies of the HIV-1 protease inhibitive didemnaketals: stereocontrolled synthetic approach to the key mother spiroketals.

Synthetic Studies of an Analogue of Hiv-1 Protease Inhibitors of Didemnaketals: Construction of the C1-C8 Intermediate

A convergent synthesis of the spiroketal moiety of the HIV-1 protease inhibitors didemnaketals

Synthetic Studies of Didemnaketals Analogue-Construction of the Intermediate （3S,5s,6r）-3,7-dimethyl-5,6,7-trihydroxy-octanal

Synthetic studies of the HIV-1 protease inhibitive didemnaketals: precise and stereocontrolled synthesis of the key mother spiroketal

Synthetic Studies of Didemnaketal Analogue—construction of the (+)- and (−)-5,6-dihydroxy-3,7-dimethyl-octanal Intermediates

Synthetic studies of the HIV-1 protease inhibitive didemnaketals: stereocontrolled synthesis of an ester side chain

Synthesis of the C5–C30 fragment of cyclodidemniserinol trisulfate via I2-mediated deprotection and ring closure tandem reaction

Total Synthesis of Anti-Hiv Agent Chloropeptin I.

Discovery and Synthesis of Novel Beesioside I Derivatives with Potent Anti-Hiv Activity.

Toward the Natural Didemnaketal A: Total Synthesis of the Isomer of Didemnaketal A

Study on Synthesis of Ethyl 3-Oxo-(s)-(+)-6,7-di-o- Isopropylidene-6,7-Dihydroxyheptanoate

Piperidine Scaffold As the Novel P2-ligands in Cyclopropyl-Containing HIV-1 Protease Inhibitors: Structure-based Design, Synthesis, Biological Evaluation and Docking Study

Bioisosterism-based Design and Enantiomeric Profiling of Chiral Hydroxyl-Substituted Biphenyl-Diarylpyrimidine Nonnucleoside HIV-1 Reverse Transcriptase Inhibitors.